QPS buys stake in Bioserve to expand Phase I business
QPS has bought a majority stake in India’s Bioserve Clinical Research to bolster its Phase I and bioanalytical business.
Archives for January 26, 2011
Weak anti-counterfeiting slowing ASEAN harmonisation
Failure to reduce counterfeiting is one of a number of issues slowing healthcare regulation harmonisation in ASEAN.
Pfizer brings “best minds together” at New York Centre for Therapeutic Innovation
Pfizer’s Centres for Therapeutic Innovation (CTI) has teamed up with seven New York research hospitals to accelerate biomedical research into life-saving medicines, with a focus on biologics.
US must innovate to prosper in globalised market; Obama
The US must improve innovation and education to prosper in the new globalised, outsourced operating environment, according to President Obama.
A new job for former FDA chief and Catalent packaging appointments – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new job for former FDA chief and Catalent packaging appointments.
Big pharma reacts to Putin’s warning by increasing Russian manufacturing
GSK and Teva will invest in Russian drug manufacturing in response to PM Vladimir Putin’s warning that Pharmas will face restrictions if they fail to boost local production and transfer technology.
Quintiles opens Phase I unit in India
Contract Research Organisation (CRO) Quintiles has opened a Phase I facility in Hyderabad, India, citing increasing demand for efficiency in early-phase drug research in the country.
Pharmsynthez buys Kevelt to grow in Europe
Russian drugmaker Pharmsynthez has bought Estonian manufacturer Kevelt in a bid to expand its international business.
PsiOxus Therapeutics sees industry demand for oncolytic vaccines
PsiOxus Therapeutics has predicted growing demand for oncolytic vaccines, citing recent industry acquisitions as evidence of the need for novel treatments for cancer.